Susquehanna International Group, LLP Sol Gel Technologies Ltd. Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$0.66 - $1.05 $14,742 - $23,453	22,337 New	22,337 $19,000
Q2 2022 Aug 15, 2022	SELL	$4.1 - $7.36 $51,442 - $92,345	-12,547 Reduced 42.88%	16,715 $69,000
Q1 2022 May 16, 2022	BUY	$6.64 - $8.21 $82,336 - $101,804	12,400 Added 73.54%	29,262 $223,000
Q4 2021 Feb 14, 2022	BUY	$6.57 - $9.78 $28,086 - $41,809	4,275 Added 33.96%	16,862 $125,000
Q3 2021 Nov 15, 2021	BUY	$8.85 - $12.5 $111,394 - $157,337	12,587 New	12,587 $126,000
Q3 2018 Nov 14, 2018	SELL	$6.2 - $7.8 $110,626 - $139,175	-17,843 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$7.5 - $10.71 $57,870 - $82,638	7,716 Added 76.19%	17,843 $141,000
Q1 2018 May 15, 2018	BUY	$10.3 - $13.64 $104,308 - $138,132	10,127 New	10,127 $104,000

5.35M

1.5K

Ticker SLGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,129,500
Market Cap $12.5M
Description
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.